These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
673 related items for PubMed ID: 16493425
1. Pre-erythrocytic malaria vaccines: towards greater efficacy. Hill AV. Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425 [Abstract] [Full Text] [Related]
2. The dog that did not bark: malaria vaccines without antibodies. Heppner DG, Schwenk RJ, Arnot D, Sauerwein RW, Luty AJ. Trends Parasitol; 2007 Jul; 23(7):293-6. PubMed ID: 17512252 [Abstract] [Full Text] [Related]
3. The development of malaria vaccines: SPf66--what next? Tanner M, Alonso PL. Schweiz Med Wochenschr; 1996 Jul 09; 126(27-28):1210-5. PubMed ID: 8766632 [Abstract] [Full Text] [Related]
4. [Immunization against malaria]. Méchai F, Loulergue P, Bouchaud O. Rev Prat; 2012 May 09; 62(5):605-10. PubMed ID: 22730782 [Abstract] [Full Text] [Related]
5. Towards a blood-stage vaccine for malaria: are we following all the leads? Good MF. Nat Rev Immunol; 2001 Nov 09; 1(2):117-25. PubMed ID: 11905819 [Abstract] [Full Text] [Related]
6. Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria. Walther M. Expert Rev Vaccines; 2006 Feb 09; 5(1):81-93. PubMed ID: 16451110 [Abstract] [Full Text] [Related]
7. [The malaria vaccine candidate RTS,S/AS is in phase III clinical trials]. Cohen J, Benns S, Vekemans J, Leach A. Ann Pharm Fr; 2010 Nov 09; 68(6):370-9. PubMed ID: 21073995 [Abstract] [Full Text] [Related]
8. Immune effector mechanisms in malaria. Good MF, Doolan DL. Curr Opin Immunol; 1999 Aug 09; 11(4):412-9. PubMed ID: 10448141 [Abstract] [Full Text] [Related]
9. The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Good MF, Stanisic D, Xu H, Elliott S, Wykes M. Immunol Rev; 2004 Oct 09; 201():254-67. PubMed ID: 15361246 [Abstract] [Full Text] [Related]
10. Save the children. Hoffman S. Nature; 2004 Aug 19; 430(7002):940-1. PubMed ID: 15318239 [No Abstract] [Full Text] [Related]
11. Immune evasion by malaria parasites: a challenge for vaccine development. Casares S, Richie TL. Curr Opin Immunol; 2009 Jun 19; 21(3):321-30. PubMed ID: 19493666 [Abstract] [Full Text] [Related]
12. Vaccine development against malaria. Matuschewski K. Curr Opin Immunol; 2006 Aug 19; 18(4):449-57. PubMed ID: 16765576 [Abstract] [Full Text] [Related]
14. Construction and evaluation of a multistage combination vaccine against malaria. Zhang Q, Xue X, Qu L, Pan W. Vaccine; 2007 Mar 01; 25(11):2112-9. PubMed ID: 17241708 [Abstract] [Full Text] [Related]
18. The Plasmodium sporozoite survives RTS,S vaccination. Snounou G, Grüner AC, Müller-Graf CD, Mazier D, Rénia L. Trends Parasitol; 2005 Oct 01; 21(10):456-61. PubMed ID: 16109504 [Abstract] [Full Text] [Related]
19. Parasitology. Malaria--from infants to genomics to vaccines. Long CA, Hoffman SL. Science; 2002 Jul 19; 297(5580):345-7. PubMed ID: 12130768 [No Abstract] [Full Text] [Related]